Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
New classes of drugs like Wegovy (a GLP-1 ... The enormous popularity and demand of weight loss drugs in America opens the door for compounding, which is the process of mixing or altering ...
Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...
Before using the weight loss drug, the actress shed 80 pounds through ... Ozempic to slim down in time for the “Real Housewives of New Jersey” Season 13 reunion taping.
The new panel of weight loss drugs can help. According to the National Institutes of Health, “Prescription medications to treat overweight and obesity work in different ways. For example ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback